Molecular dynamics simulation of the P2Y14 receptor. Ligand docking and identification of a putative binding site of the distal hexose moiety

Bioorganic & Medicinal Chemistry Letters
2007.0

Abstract

A rhodopsin-based homology model of the P2Y14 receptor was inserted into a phospholipid bilayer and refined by molecular dynamics (MD) simulation. The binding modes of several known agonists, namely UDP-glucose and its analogues, were proposed using automatic molecular docking combined with Monte Carlo Multiple Minimum calculations. Compared to other P2Y receptors, the P2Y14 receptor has an atypical binding mode of the nucleobase, ribose, and phosphate moieties. The diphosphate moiety interacts with only one cationic residue, namely Lys171 of EL2, while in other P2Y receptor subtypes three Arg or Lys residues interact with the phosphate chain. Two other conserved cationic residues, namely Arg253 (6.55) and Lys277 (7.35) of the P2Y14 receptor together with two anionic residues (Glu166 and Glu174, located in EL2), are likely involved in interactions with the distal hexose moiety.

Knowledge Graph

Similar Paper

Molecular dynamics simulation of the P2Y14 receptor. Ligand docking and identification of a putative binding site of the distal hexose moiety
Bioorganic & Medicinal Chemistry Letters 2007.0
Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligands
Bioorganic & Medicinal Chemistry 2015.0
Structure−Activity Relationship of Uridine 5‘<b>-</b>Diphosphoglucose Analogues as Agonists of the Human P2Y<sub>14</sub> Receptor
Journal of Medicinal Chemistry 2007.0
Molecular recognition in the P2Y14 receptor: Probing the structurally permissive terminal sugar moiety of uridine-5′-diphosphoglucose
Bioorganic &amp; Medicinal Chemistry 2009.0
Human P2Y<sub>6</sub> Receptor:  Molecular Modeling Leads to the Rational Design of a Novel Agonist Based on a Unique Conformational Preference
Journal of Medicinal Chemistry 2005.0
Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y<sub>2</sub>Receptor
Journal of Medicinal Chemistry 2017.0
Human P2Y<sub>14</sub>Receptor Agonists: Truncation of the Hexose Moiety of Uridine-5′-Diphosphoglucose and Its Replacement with Alkyl and Aryl Groups
Journal of Medicinal Chemistry 2010.0
Molecular Modeling of the Human P2Y<sub>2</sub> Receptor and Design of a Selective Agonist, 2‘-Amino-2‘-deoxy-2-thiouridine 5‘-Triphosphate
Journal of Medicinal Chemistry 2007.0
Molecular Recognition in Purinergic Receptors. 2. Diastereoselectivity of the h-P2Y<sub>1</sub>-Receptor
Journal of Medicinal Chemistry 2004.0
Molecular Modeling and Molecular Dynamics Simulation of the Human A<sub>2B</sub>Adenosine Receptor. The Study of the Possible Binding Modes of the A<sub>2B</sub>Receptor Antagonists
Journal of Medicinal Chemistry 2005.0